Oncology

Dr Yu said that it is crucial for providers' voices to be heard in pathway development.

Patients with non-Hodgkin's lymphoma who have received 8 or more CT scans have a 2-fold risk for secondary primary malignancies, new research shows.

The panelists discussed and shared examples of how payers and providers are collaborating to develop pathway guidelines.

Seema Sonnad, PhD, associate editor for The American Journal of Managed Care, and director of Health Services Research at The Value Institute at Christiana Care Health System, led a panel discussion that focused on oncology clinical pathway adherence.

Caloric restriction in women with the triple negative disease was found to reduce incidence of metastases in a pre-clinical model.

Scientists in Germany have developed a vaccine that they say provides some protection against brain tumors in mice.

Avastin is the first biologic medicine to receive a CHMP positive opinion for the most difficult to treat form of ovarian cancer.

The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Hospital outpatient prices for standard blood tests, cancer screening and other services varied widely and were sharply higher, on average, than prices charged by ambulatory clinics and independent doctors, an analysis of autoworker health-plan spending across 18 cities has found.

Results indicate that nivolumab is likely to prolong survival in advanced melanoma.

Safety concerns over the PARP inhibitor warranted the request for additional data.

Phase II study findings show only marginal positive effects of third-line treatment with afatinib for advanced non-small-cell lung cancer (NSCLC) in patients with wild-type epidermal growth-factor receptor (EGFR) tumour status.

The FDA staff report questioned the unusually poor performance of the control group used in the study.

Newly diagnosed multiple myeloma patients undergoing ASCT showed a significant improvement in survival.

The US FDA has warned that intravenous administration docetaxal formulations contain alcohol and may cause intoxication among patients. A product label revision is being made.

Ira Klein, MD, MBA, FACP, chief medical officer, National Accounts Clinical Sales & Strategy, Aetna, suggests that oncology practices lack a sense of economic perspective that would otherwise allow them to offer a variety of services to their patients.

A panel asks: "Due to the ACA, who is now presenting with cancer? Who is walking through the door and is there a difference between patients since the ACA implementation?"

From 20 months to upto 5 years, blocking CD20 significantly improved OS in CLL patients.

For patients who survive cancer, annual medical costs can be nearly double those of non-cancer patients.

Twenty-two Democratic lawmakers have asked the National Institutes of Health to publicly disclose demographic data for all clinical trials posted on ClinicalTrials.gov.

The derivative slowed tumor growth, shrunk tumors, and extended the life of the mice.

BRCA2 mutation, a genetic risk factor for breast and ovarian cancer, has been implicated in squamous cell lung cancer among cigarette smokers.

Pfizer's deal with the French company will ensure a market share in the promising immunooncology field.

The oncolytic adenovirus vaccine, DNX-2401, being developed by DNAtrix to treat recurrent glioblastoma, has received a fast-track status by the FDA.

In community-based radiology practice, mammography screening with 3D digital breast tomosynthesis (DBT) yielded lower recall rates, an increased overall cancer detection rate, and an increased detection rate for invasive cancer compared with 2D digital mammography (DM).